|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cost of revenues | |||||
| Revenues | |||||
| Cost of revenues (including cost of revenues resulting from transactions with a related party of $261,257 and $160,502 for the years ended December 31, 2025 and 2024, respectively) | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling expenses | |||||
| General and administrative expenses (including general and administrative expenses resulting from transactions with a related party of $29,048 and $41,786 for the years ended December 31, 2025 and 2024, respectively) | |||||
| Research and development expenses | |||||
| Impairment of intangible asset | |||||
| Impairment of goodwill | |||||
| Total operating expenses | |||||
| Loss from continuing operations | |||||
| Other income (expenses): | |||||
| Changes in fair value of investments in marketable securities | |||||
| Changes in fair value of investment in warrants | |||||
| Loss on sale of warrants | |||||
| Impairment of investment in equity securities | |||||
| Changes in fair value of derivative liability | |||||
| Loss on forgiveness of note receivable | |||||
| Interest income | |||||
| Interest expenses | |||||
| Government grants | |||||
| Other income | |||||
| Other expenses | |||||
| Total other income (expenses) | |||||
| Total other expenses | |||||
| Loss from continuing operations before income tax expense (benefit) | |||||
| Income tax expense (benefit) | |||||
| Net loss from continuing operations | |||||
| Income (loss) from discontinued operations, net of income tax | |||||
| Net income (loss) | |||||
| Less: net loss attributable to non-controlling interests | |||||
| Net income (loss) attributable to HeartCore Enterprises, Inc. | |||||
| Dividends accrued on Series A convertible preferred shares | |||||
| Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders | |||||
| Other comprehensive loss: | |||||
| Foreign currency translation adjustment | |||||
| Total comprehensive income (loss) | |||||
| Less: comprehensive loss attributable to non-controlling interests | |||||
| Comprehensive income (loss) attributable to HeartCore Enterprises, Inc. | |||||
| Net income (loss) from continuing operations attributable to HeartCore Enterprises, Inc. per common share | |||||
| Basic | |||||
| Diluted | |||||
| Income (loss) from discontinued operations per common share | |||||
| Basic | |||||
| Diluted | |||||
| Net income (loss) attributable to HeartCore Enterprises, Inc. per common share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares outstanding | |||||
| Basic | |||||
| Diluted | |||||
Loading...